Timber Pharmaceuticals Announces Bankruptcy and Stock Cancellation

Timber Pharmaceuticals (TMBRQ) has shared an update.

Trex Wind-down, Inc., formerly known as Timber Pharmaceuticals, has confirmed its Chapter 11 bankruptcy plan, leading to the cancellation of all its common stock shares, with no recovery for shareholders. The plan’s effectiveness will also result in the company deregistering its securities and suspending reporting obligations, as it files the necessary amendments and forms with the SEC. While the company has made forward-looking statements regarding these actions, it cautions that actual results may vary and future developments are uncertain.

Learn more about TMBRQ stock on TipRanks’ Stock Analysis page.